Scientific Advisor & Board Member
Edmund P. Harrigan, M.D. has served as a scientific advisor and Science Advisory Board member since 2009. Dr. Harrigan was Senior Vice President of Worldwide Safety and Regulatory for Pfizer Inc. from 2012 to 2015, where he led a 3,500-person team across 80 countries, responsible for collecting, interpreting and reporting clinical safety data for more than 600 marketed products, and managing regulatory interactions with global health agencies. Dr. Harrigan’s previous executive leadership roles at Pfizer include serving as Senior Vice President, Head of Worldwide Business Development, Senior Vice President, Head of Worldwide Regulatory Affairs and Quality Assurance, and Vice President, Head of Neuroscience and Ophthalmology. Earlier in his career at Pfizer, Dr. Harrigan served as Vice President of Clinical Development, Therapeutic Area Head, CNS and Pain. Before entering the pharmaceutical industry in 1990, Dr. Harrigan was a practicing neurologist for seven years. He currently serves on the Boards of Directors of Karuna Pharmaceuticals, Acadia Pharmaceuticals, and Lyndra Inc. Dr. Harrigan obtained his M.D. from the University of Massachusetts.
At MMS, Dr. Harrigan supports the MMS teams in a scientific capacity and offers advice to the staff on clinical and regulatory matters including MMS business related strategy. Dr. Harrigan obtained his M.D. from the University of Massachusetts, Worcester, MA.